Global Vascular Closure Devices (VCDS) Market Size By Type (5F-6F, 5F-21F), By Application (Angiography Surgery, Interventional Procedures), By Region, And Segment Forecasts, 2023 to 2032

The Global Vascular Closure Devices (VCDs) Market was valued at USD 1.2 billion in 2023 and is projected to surpass USD 2.1 billion by 2031, growing at a CAGR of 7.5% during the forecast period of 2023-2031.

The increasing prevalence of cardiovascular diseases (CVDs), growing adoption of minimally invasive surgical procedures, and rising geriatric population are driving the market growth. VCDs play a critical role in reducing access site complications and improving patient recovery times after interventional cardiovascular procedures, such as angioplasty and catheterization.

Advancements in bioresorbable closure devices and increased demand for faster hemostasis solutions are expected to propel the market further. Additionally, the shift towards ambulatory surgical centers (ASCs) for cardiovascular procedures is creating opportunities for market expansion.

Market Drivers

1. Rising Prevalence of Cardiovascular Diseases (CVDs)

Cardiovascular diseases remain the leading cause of death worldwide, driving the demand for advanced vascular closure devices. Increasing cases of peripheral vascular diseases and coronary artery diseases (CAD) are key contributors to the market's expansion.

2. Shift Towards Minimally Invasive Procedures

The preference for minimally invasive surgeries (MIS) is growing due to their lower risks, shorter hospital stays, and reduced recovery times. This has increased the adoption of vascular closure devices to enable quick post-procedure recovery.

3. Growing Number of Catheterization Procedures

With an increasing number of catheterization laboratories and interventional cardiology procedures, the need for effective closure devices has surged. VCDs are preferred over manual compression techniques due to their efficiency in achieving hemostasis.

Market Restraints

1. High Costs Associated with Vascular Closure Devices

Despite their advantages, vascular closure devices can be expensive, which limits adoption in cost-sensitive regions. Reimbursement challenges also affect market growth.

2. Risk of Complications

Although VCDs are designed to improve hemostasis, complications such as infection, vascular injury, or device failure can occur, which may impact their adoption.

Market Opportunity

1. Advancements in Bioresorbable Closure Devices

The introduction of bioresorbable vascular closure devices (that dissolve within the body) is a significant market opportunity. These innovations improve patient outcomes and eliminate the need for device removal.

2. Growth in Emerging Markets

Developing countries in Asia-Pacific and Latin America are investing heavily in healthcare infrastructure, which presents lucrative opportunities for market players to expand their presence.

3. Expansion of Outpatient & Ambulatory Surgical Centers (ASCs)

The rise in outpatient cardiovascular procedures in ASCs is increasing demand for VCDs, as these centers require efficient and fast closure techniques to optimize patient throughput.

Market by Product Type Insights

1. Active Vascular Closure Devices

The largest segment, contributing significantly to market revenue.

Includes suture-based, collagen plug-based, and clip-based closure devices.

Preferred for their faster hemostasis and reduced complications.

2. Passive Vascular Closure Devices

Comprises manual compression-assisted and sealant-based devices.

Lower cost but slower closure time compared to active devices.

Market by End-use Insights

1. Hospitals

Largest segment, accounting for over 55% of the market in 2023.

High adoption due to a large number of cardiovascular procedures performed in hospital settings.

2. Ambulatory Surgical Centers (ASCs)

Expected to witness the highest CAGR during 2023-2031.

Growing adoption of same-day discharge procedures is driving demand.

3. Specialty Cardiology Clinics

Increasing outpatient cardiac interventions are boosting demand for VCDs in specialty clinics.

Market by Regional Insights

1. North America

Dominated the market in 2023, driven by high prevalence of cardiovascular diseases and advanced healthcare infrastructure.

Presence of leading market players and favorable reimbursement policies.

2. Europe

Strong market due to technological advancements and rising geriatric population.

Countries like Germany, UK, and France are key contributors.

3. Asia-Pacific

Fastest-growing region, led by increasing healthcare investments, growing patient awareness, and improving access to cardiac treatments.

India and China are emerging as major markets.

4. Latin America and Middle East & Africa (MEA)

Steady growth, driven by expanding private healthcare facilities and increasing adoption of minimally invasive procedures.

Competitive Scenario

Key players in the Global Vascular Closure Devices (VCDs) Market include:

Abbott Laboratories

Cardinal Health

Terumo Corporation

Teleflex Incorporated

Vasorum Ltd.

Medtronic plc

Cardiva Medical, Inc.

Morris Innovative, Inc.

These companies are focusing on product innovations, strategic collaborations, and market expansion initiatives to maintain their competitive edge.

Recent Market Developments

In 2023, Abbott launched an advanced bioresorbable vascular closure device, improving patient outcomes and reducing procedure times.

Medtronic acquired a vascular closure device startup in 2024, expanding its product portfolio.

Teleflex introduced a next-generation clip-based vascular closure device, enhancing safety and efficiency.

Cardinal Health partnered with leading hospitals in North America to expand the adoption of minimally invasive closure solutions.

Scope of Work – Global Vascular Closure Devices (VCDs) Market

Report Metric Details

Market Size (2023) USD 1.2 billion

Projected Market Size (2031) USD 2.1 billion

CAGR (2023-2031) 7.5%

Key Segments by Product Type Active Closure Devices, Passive Closure Devices

Key Segments by End-use Hospitals, ASCs, Specialty Clinics

Leading Region North America

Key Players Abbott, Medtronic, Terumo, Teleflex, Cardinal Health

Growth Drivers Rising Cardiovascular Diseases, Minimally Invasive Surgery Adoption

Opportunities Bioresorbable Devices, Emerging Markets Growth

FAQs

1. What is the current market size of the Global Vascular Closure Devices (VCDs) Market?

The market was valued at USD 1.2 billion in 2023 and is projected to grow significantly by 2031.

2. What is the major growth driver of the Vascular Closure Devices (VCDs) Market?

The increasing prevalence of cardiovascular diseases (CVDs) and the shift towards minimally invasive procedures are the primary growth drivers.

3. Which is the largest region during the forecast period in the Vascular Closure Devices (VCDs) Market?

North America dominated the market due to advanced healthcare infrastructure and high adoption of vascular closure devices.

4. Which segment accounted for the largest market share in the Vascular Closure Devices (VCDs) Market?

The Active Vascular Closure Devices segment accounted for the largest market share, due to higher efficiency in achieving hemostasis.

5. Who are the key market players in the Vascular Closure Devices (VCDs) Market?

Key players include Abbott Laboratories, Cardinal Health, Terumo Corporation, Teleflex, Medtronic, and Vasorum Ltd.

This comprehensive and structured market report provides a detailed analysis of the Global Vascular Closure Devices (VCDs) Market, including its market size, key trends, drivers, restraints, opportunities, competitive landscape, and regional outlook for the period 2023-2031. 🚀